{"&cites=13522944793194834082&as_sdt=2005&sciodt=0,5&hl=en&scioq=rheumatology":[{"title":"Efficacy of B-cell–targeted therapy with rituximab in patients with rheumatoid arthritis","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa032534","authors":["JCW Edwards","JCW Edwards L Szczepański…"],"year":2004,"numCitations":2945,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa032534","citationUrl":"http://scholar.google.com/scholar?cites=13290738830402611527&as_sdt=2005&sciodt=0,5&hl=en&scioq=rheumatology","relatedUrl":"http://scholar.google.com/scholar?q=related:R2mjhIwwcrgJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13290738830402611527&hl=en&as_sdt=2005&sciodt=0,5&scioq=rheumatology","publication":"Mass Medical Soc","p":1,"exp":1596893542891},{"title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","url":"https://ard.bmj.com/content/73/3/492.short","authors":["JS Smolen","JS Smolen R Landewé","JS Smolen R Landewé FC Breedveld…"],"year":2014,"numCitations":2331,"pdf":"https://ard.bmj.com/content/annrheumdis/73/3/492.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=15630718529220191090&as_sdt=2005&sciodt=0,5&hl=en&scioq=rheumatology","relatedUrl":"http://scholar.google.com/scholar?q=related:ciNJ7q9369gJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15630718529220191090&hl=en&as_sdt=2005&sciodt=0,5&scioq=rheumatology","publication":"ard.bmj.com"},{"title":"The PREMIER study: a multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or …","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.21519","authors":["FC Breedveld","FC Breedveld MH Weisman…"],"year":2006,"numCitations":2133,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.21519","citationUrl":"http://scholar.google.com/scholar?cites=12894171158113881425&as_sdt=2005&sciodt=0,5&hl=en&scioq=rheumatology","relatedUrl":"http://scholar.google.com/scholar?q=related:UQ13IFpM8bIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12894171158113881425&hl=en&as_sdt=2005&sciodt=0,5&scioq=rheumatology","publication":"Wiley Online Library"},{"title":"Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial …","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.22025","authors":["SB Cohen","SB Cohen P Emery","SB Cohen P Emery MW Greenwald…"],"year":2006,"numCitations":1927,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.22025","citationUrl":"http://scholar.google.com/scholar?cites=1042898541175730086&as_sdt=2005&sciodt=0,5&hl=en&scioq=rheumatology","relatedUrl":"http://scholar.google.com/scholar?q=related:pm-Nm7IeeQ4J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1042898541175730086&hl=en&as_sdt=2005&sciodt=0,5&scioq=rheumatology","publication":"Wiley Online Library"},{"title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","url":"https://ard.bmj.com/content/76/6/960.abstract","authors":["JS Smolen","JS Smolen R Landewé","JS Smolen R Landewé J Bijlsma…"],"year":2017,"numCitations":1810,"pdf":"http://eprints.whiterose.ac.uk/116927/1/annrheumdis-2016-210715.pdf","citationUrl":"http://scholar.google.com/scholar?cites=532213958404936786&as_sdt=2005&sciodt=0,5&hl=en&scioq=rheumatology","relatedUrl":"http://scholar.google.com/scholar?q=related:UhQ7f8bNYgcJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=532213958404936786&hl=en&as_sdt=2005&sciodt=0,5&scioq=rheumatology","publication":"ard.bmj.com"},{"title":"Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American …","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.1780390105","authors":["AM Van Gestel","AM Van Gestel MLL Prevoo…"],"year":1996,"numCitations":1677,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.1780390105","citationUrl":"http://scholar.google.com/scholar?cites=6366976276639904858&as_sdt=2005&sciodt=0,5&hl=en&scioq=rheumatology","relatedUrl":"http://scholar.google.com/scholar?q=related:WvR1njALXFgJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=6366976276639904858&hl=en&as_sdt=2005&sciodt=0,5&scioq=rheumatology","publication":"Wiley Online Library"},{"title":"Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.20568","authors":["EW St. Clair","EW St. Clair DMFM Van Der Heijde…"],"year":2004,"numCitations":1425,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.20568","citationUrl":"http://scholar.google.com/scholar?cites=10013342158858176201&as_sdt=2005&sciodt=0,5&hl=en&scioq=rheumatology","relatedUrl":"http://scholar.google.com/scholar?q=related:yUYv-aOJ9ooJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10013342158858176201&hl=en&as_sdt=2005&sciodt=0,5&scioq=rheumatology","publication":"Wiley Online Library"},{"title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial","url":"https://www.sciencedirect.com/science/article/pii/S0140673608604535","authors":["JS Smolen","JS Smolen A Beaulieu","JS Smolen A Beaulieu A Rubbert"],"year":2008,"numCitations":1424,"citationUrl":"http://scholar.google.com/scholar?cites=16483260656911595476&as_sdt=2005&sciodt=0,5&hl=en&scioq=rheumatology","relatedUrl":"http://scholar.google.com/scholar?q=related:1DdjQzxOwOQJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16483260656911595476&hl=en&as_sdt=2005&sciodt=0,5&scioq=rheumatology","publication":"Elsevier"},{"title":"Abatacept for rheumatoid arthritis refractory to tumor necrosis factor α inhibition","url":"https://www.nejm.org/doi/full/10.1056/nejmoa050524","authors":["MC Genovese","MC Genovese JC Becker","MC Genovese JC Becker M Schiff…"],"year":2005,"numCitations":1374,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa050524","citationUrl":"http://scholar.google.com/scholar?cites=13710448149404285610&as_sdt=2005&sciodt=0,5&hl=en&scioq=rheumatology","relatedUrl":"http://scholar.google.com/scholar?q=related:qnqnaPNLRb4J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13710448149404285610&hl=en&as_sdt=2005&sciodt=0,5&scioq=rheumatology","publication":"Mass Medical Soc"},{"title":"American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.30129","authors":["DT Felson","DT Felson JS Smolen","DT Felson JS Smolen G Wells","DT Felson JS Smolen G Wells B Zhang…"],"year":2011,"numCitations":1363,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.30129","citationUrl":"http://scholar.google.com/scholar?cites=12290633109847859973&as_sdt=2005&sciodt=0,5&hl=en&scioq=rheumatology","relatedUrl":"http://scholar.google.com/scholar?q=related:BeMi4bEZkaoJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12290633109847859973&hl=en&as_sdt=2005&sciodt=0,5&scioq=rheumatology","publication":"Wiley Online Library"}]}